Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 24 of 57
Trial of Indomethacin in Chronic Pancreatitis
NCT04207060
Resilient Living Program for Patients With Advanced Cancer and Their Caregivers
NCT04480008
Community Paramedicine Program to Improve Diabetes Care Quality, Equity, and Outcomes
NCT04385758
Antihistamines in Eosinophilic Esophagitis
NCT04248712
Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies
NCT04258631
Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes
NCT04073394
Handheld Dynamometer During Awake Craniotomy Pilot
NCT04742231
Ultrasound Guided - Incisionless Threaded Carpal Tunnel Release
NCT04101955
Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear
NCT04442464
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
NCT04456140
Fractures and Bone Disease in Living Kidney Donors
NCT04810884
Feasibility in the Prophylaxis of Radiation Dermatitis Severity
NCT04715386
Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.
NCT04549246
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
NCT04129411
Wellness Coaching for Caregivers of Thoracic Transplant Candidates
NCT04245228
PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer
NCT04310540
Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study
NCT04398368
Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
NCT04408586
Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations
NCT04558307
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
NCT04417998
Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection
NCT04301934
Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection
NCT04694638
Pain Management Intervention Preparatory to a Future Pragmatic Trial
NCT04336592
Risks of COVID19 in the Pregnant Population
NCT04379284
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
NCT04383587
Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy
NCT04410731
Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
NCT04294225
Comparing MRI to CT on Pediatric Craniosynostosis.
NCT04704284
Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry
NCT04323787
Exploring Psychometric Properties of a New Version of the 6MWT in the Acute Stroke Population
NCT04515693
Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients
NCT04256512
Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation
NCT04316468
Non-intrusive Detection of Temporary Neurologic Impairment By Opioids
NCT04223609
Ultrasonic Perfusion Estimation in Calf Muscle
NCT04755335
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
NCT04217694
Microbiome and Immunologic Analysis - Women With Endometriosis
NCT04159740
Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides
NCT03695471
Improving the Quality of Dementia Care Through Innovative Redesign of the Memory Care Environment
NCT04350060
The FAITH! Trial: A mHealth Intervention to Improve Cardiovascular Health Among African-Americans
NCT03777709
Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates
NCT04474184
Intravascular Volume Expansion to Neuroendocrine-Renal Function Profiles in Chronic Heart Failure
NCT04156854
Investigating the Effect of Obesity on Eosinophil Recruitment in Human Adipose Tissue
NCT04234295
Pilot Social Network Weight Loss Intervention
NCT04273503
Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery
NCT04369703
Augmented Human Intelligence in Major Depressive Disorder
NCT04355650
Effect of Coaching on Surgeon Well-Being, Job Satisfaction, & Fulfillment
NCT04235751
Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions
NCT05674123
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
NCT03979508
Unmasking Right Ventricular and Pulmonary Derangements With Exercise and Oxygen in Early Stage Cardiopulmonary Diseases
NCT03911856
Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)
NCT04047810
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.